Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edesa Biotech (EDSA) Enterprise Value (2016 - 2022)

Edesa Biotech's Enterprise Value history spans 10 years, with the latest figure at -$12.8 million for Q2 2022.

  • For Q2 2022, Enterprise Value fell 59.06% year-over-year to -$12.8 million; the TTM value through Jun 2022 reached -$12.8 million, down 59.06%, while the annual FY2021 figure was -$7.8 million, 8.67% down from the prior year.
  • Enterprise Value for Q2 2022 was -$12.8 million at Edesa Biotech, up from -$15.9 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$3.0 million in Q1 2019 and bottomed at -$15.9 million in Q1 2022.
  • The 5-year median for Enterprise Value is -$7.0 million (2020), against an average of -$7.6 million.
  • The largest annual shift saw Enterprise Value skyrocketed 55.88% in 2018 before it tumbled 129.77% in 2020.
  • A 5-year view of Enterprise Value shows it stood at -$5.0 million in 2018, then increased by 12.87% to -$4.3 million in 2019, then crashed by 45.73% to -$6.3 million in 2020, then grew by 6.73% to -$5.9 million in 2021, then plummeted by 117.81% to -$12.8 million in 2022.
  • Per Business Quant, the three most recent readings for EDSA's Enterprise Value are -$12.8 million (Q2 2022), -$15.9 million (Q1 2022), and -$5.9 million (Q4 2021).